Direkt zum Inhalt
Merck
Alle Fotos(1)

Wichtige Dokumente

Gesamtdokumentation anzeigen

F0040010

Fenbendazol-Unreinheit A

European Pharmacopoeia (EP) Reference Standard

Synonym(e):

Carbendazim, BCM, Methyl-2-benzimidazolcarbamat, Methyl-benzimidazol-2-ylcarbamat

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)

About This Item

Empirische Formel (Hill-System):
C9H9N3O2
CAS-Nummer:
10605-21-7
Molekulargewicht:
191.19
Beilstein:
649044
MDL-Nummer:
MFCD00055390
UNSPSC-Code:
41116107
PubChem Substanz-ID:
329799622
NACRES:
NA.24

Qualität

pharmaceutical primary standard

API-Familie

fenbendazole

Hersteller/Markenname

EDQM

mp (Schmelzpunkt)

>300 °C (lit.)

Anwendung(en)

pharmaceutical (small molecule)

Format

neat

Lagertemp.

2-8°C

SMILES String

COC(=O)Nc1nc2ccccc2[nH]1

InChI

1S/C9H9N3O2/c1-14-9(13)12-8-10-6-4-2-3-5-7(6)11-8/h2-5H,1H3,(H2,10,11,12,13)

InChIKey

TWFZGCMQGLPBSX-UHFFFAOYSA-N

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Allgemeine Beschreibung

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung

Fenbendazole impurity A EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Verpackung

Dieses Produkt wird, wie von der entsprechenden Pharmakopöe geliefert, angeboten. Die aktuellen Mengeneinheiten finden Sie im Referenzsubstanzen-Katalog der EDQM.

Sonstige Hinweise

Sales restrictions may apply.

Ähnliches Produkt

Produkt-Nr.
Beschreibung
Preisangaben

1269403

Fenbendazol, United States Pharmacopeia (USP) Reference Standard

F0040000

Fenbendazol, European Pharmacopoeia (EP) Reference Standard

F0040020

Fenbendazol-Unreinheit B, European Pharmacopoeia (EP) Reference Standard

1269414

Fenbendazol-verwandte Verbindung A, United States Pharmacopeia (USP) Reference Standard

1269425

Fenbendazol-verwandte Verbindung B, United States Pharmacopeia (USP) Reference Standard

PHR1832

Fenbendazol, Pharmaceutical Secondary Standard; Certified Reference Material

BP692

Fenbendazol, British Pharmacopoeia (BP) Reference Standard

PHR2863

Fenbendazol-verwandte Verbindung B, certified reference material, pharmaceutical secondary standard

Signalwort

Danger

Gefahreneinstufungen

Aquatic Acute 1 - Aquatic Chronic 1 - Muta. 1B - Repr. 1B - Skin Sens. 1

Lagerklassenschlüssel

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 3

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

Leider sind derzeit keine COAs für dieses Produkt online verfügbar.

Wenn Sie Hilfe benötigen, wenden Sie sich bitte an Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Kunden haben sich ebenfalls angesehen

Slide 1 of 1

1 of 1

Carbendazim PESTANAL®, analytical standard

Supelco

45368

Carbendazim

Christoph Thalhammer et al.
Nephrology (Carlton, Vic.), 20(2), 91-95 (2014-10-28)
Haemodynamic stability of patients during haemodialysis (HD) sessions is of pivotal importance and accurate determination of dry weight remains a challenge. Little information is available about central venous and aortic pressure during dialysis. In this pilot study we used a
Przemyslaw Szafranski et al.
European journal of human genetics : EJHG, 23(2), 173-179 (2014-05-16)
Genomic copy-number variations (CNVs) constitute an important cause of epilepsies and other human neurological disorders. Recent advancement of technologies integrating genome-wide CNV mapping and sequencing is rapidly expanding the molecular field of pediatric neurodevelopmental disorders. In a previous study, a
Bin He et al.
Proceedings of the National Academy of Sciences of the United States of America, 111(51), 18261-18266 (2014-12-10)
The androgen receptor (AR) is a key driver of prostate cancer (PC), even in the state of castration-resistant PC (CRPC) and frequently even after treatment with second-line hormonal therapies such as abiraterone and enzalutamide. The persistence of AR activity via
Ismail Kocyigit et al.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 34(7), 781-790 (2014-01-05)
In this study our aim was to evaluate the relationship between degree of fluid status and arterial stiffness measured by pulse wave velocity (PWV) in peritoneal dialysis (PD) patients. Fluid status was determined by different methods including fluid overload measured
Petra Hegerová et al.
Nutrition (Burbank, Los Angeles County, Calif.), 31(1), 166-170 (2014-12-04)
An acute disease is regularly associated with inflammation, decreased food intake, and low physical activity; the consequence is loss of muscle mass. However, the restoration of muscle tissue is problematic, especially in older patients. Loss of muscle mass leads to
Alle zugehörigen Dokumente anzeigen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.